Boucher & Muir Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 1954-09-24 and was issued with the 000140474 ACN. Its Australian Business Number is 58000140474. Since 2020-01-01, the company is headquartered in NSW, post code 2060. The previous headquarters were located in NSW 2065 (from 2014-08-22 to 2020-01-01), NSW 2065 (from 2014-01-11 to 2014-08-22), and NSW 2065 (from 2000-06-17 to 2014-01-11). Boucher & Muir Pty Ltd was registered for the GST on 2000-07-01. Boucher & Muir Pty Ltd has been using the Bnm Group trading name since 2008-12-23 (it needs to be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 4 trading names. The company has also used 4 business names, namely Advanz Pharma (australia) from 2018-12-03, Concordia International (australia) from 2016-07-26 to 2021-02-05 and Concordia International (australia) from 2016-07-25. The above data comes from the ABN database which was updated on 2021-03-02. Aubiz
| Status | From | To |
|---|---|---|
| Active | May 11, 2000 | current |
| Name | From | To |
|---|---|---|
| Boucher & Muir Pty Ltd | August 4, 2000 | current |
| Boucher & Muir P/l | May 11, 2000 | August 4, 2000 |
| Name | From | To |
|---|---|---|
| Advanz Pharma (australia) | December 3, 2018 | current |
| Concordia International (australia) | July 26, 2016 | February 5, 2021 |
| Concordia International (australia) | July 25, 2016 | current |
| Bnm Group | August 4, 2015 | current |
| Name | From | To |
|---|---|---|
| Bnm Group | December 23, 2008 | current |
| Boucher & Muir Pty Ltd | June 20, 2006 | current |
| Boucher & Muir Pty Ltd | April 1, 2006 | June 20, 2006 |
| Goldshield Healthcare [australia] | April 1, 2006 | current |
| Location | From | To |
|---|---|---|
| NSW 2060 | January 1, 2020 | current |
| NSW 2065 | August 22, 2014 | January 1, 2020 |
| NSW 2065 | January 11, 2014 | August 22, 2014 |
| NSW 2065 | June 17, 2000 | January 11, 2014 |
| Status | From | To |
|---|---|---|
| Registered | July 1, 2000 | current |
Advertisements
| Status | registered |
| Registration date | August 5, 2015 |
| Renewal date | September 24, 2017 |
| Address for service of documents | Level 1 134 Willoughby Rd Crows Nest NSW 2065 |
| Principal place of business | Level 1 134 Willoughby Rd Crows Nest NSW 2065 |
| Debtor representative | not applicable |
| Notified successor | not applicable |
Advertisements
| Application date: | February 10, 2003 |
| Lodgement date: | February 10, 2003 |
| Registered date: | February 10, 2003 |
| Live or dead: | Live |
| CPI status: | Registered |
| Status: | Registered/Protected |
| Mark code: | Trade Mark |
| Trademark type: | Word |
| Acceptance due date: | May 29, 2003 |
| Sealing due date: | December 12, 2003 |
| Registered from date: | February 10, 2003 |
| Sealing date: | September 22, 2003 |
| Renewal due date: | February 10, 2023 |
| Court orders: | No |
| Revocation of the acceptance: | No |
| Goods and services assistance: | No |
| Lodgement type: | Online |
| Descriptive: | Optycin, Primacin |
| Examination report number: | 1 |
| Examination class count: | 1 |
| NICE class code: | 5 |
| NICE occ number: | 1 |
| NICE description text: | Medicines |
| Suburb name: | North Sydney |
| Postcode: | 2059 |
| Australian state code: | NSW |
| Country code: | AU |
| Date | Description | Agency | Value | |
|---|---|---|---|---|
| 2007-10-31 | Drugs and Pharmaceutical Products | Defence Materiel Organisation |
55 109.45 |
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2026 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2026, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.